TABLE 6.

Summary of estimated differential CpG methylation between FAS cases and controls (FAS-CON), per CpG site.

		Unadjusted			Adjusted for age and sex
Locus	Site	FAS-CON	SE	P-value	FAS-CON	SE	P-value
H19 ICR	CpG1	1.80	0.5	<0.001	0.23	0.79	0.767
H19 ICR	CpG2	1.06	0.5	0.035	–0.49	0.79	0.537
H19 ICR	CpG3	1.17	0.5	0.019	–0.42	0.79	0.594
H19 ICR	CpG5	1.48	0.5	0.003	–0.05	0.79	0.950
H19 ICR	CpG6	1.35	0.5	0.007	–0.16	0.79	0.835
IG-DMR.A	CpG1	1.02	0.53	0.054	–0.50	0.81	0.540
IG-DMR.A	CpG2	1.07	0.53	0.043	–0.52	0.81	0.520
IG-DMR.A	CpG3	0.48	0.53	0.364	–1.01	0.81	0.216
IG-DMR.A	CpG4	0.19	0.53	0.724	–1.27	0.81	0.117
IG-DMR.A	CpG5	3.05	0.53	<0.001	1.50	0.81	0.065
IG-DMR.B	CpG6	1.34	0.53	0.012	<0.21	0.81	0.792
IG-DMR.B	CpG7	0.22	0.53	0.679	–1.31	0.81	0.106
IG-DMR.B	CpG8	0.68	0.53	0.202	–0.92	0.81	0.258
IG-DMR.B	CpG9	1.36	0.53	0.010	–0.22	0.81	0.782
IG-DMR.B	CpG10	0.24	0.53	0.646	–1.33	0.81	0.101
KvDMR1	CpG1	0.96	0.53	0.072	–0.53	0.81	0.512
KvDMR1	CpG2	0.28	0.53	0.596	–1.21	0.81	0.138
KvDMR1	CpG3	0.28	0.53	0.595	–1.20	0.81	0.141
KvDMR1	CpG4	–0.17	0.53	0.752	–1.67	0.81	0.040
KvDMR1	CpG5	–0.01	0.53	0.986	–1.43	0.81	0.079
KvDMR1	CpG6	–0.10	0.53	0.851	–1.55	0.81	0.057
KvDMR1	CpG7	–0.60	0.53	0.262	–2.12	0.81	0.009
PEG3 DMR	CpG1	–5.34	0.55	<0.001	–6.98	0.83	<0.001
PEG3 DMR	CpG2	–5.08	0.55	<0.001	–6.69	0.83	<0.001
PEG3 DMR	CpG3	–6.14	0.55	<0.001	–7.73	0.83	<0.001
PEG3 DMR	CpG4	–4.74	0.55	<0.001	–6.43	0.83	<0.001
PEG3 DMR	CpG5	–5.51	0.55	<0.001	–7.07	0.83	<0.001
PEG3 DMR	CpG6	–5.11	0.55	<0.001	–6.67	0.83	<0.001
PEG3 DMR	CpG7	–5.35	0.55	<0.001	–6.96	0.83	<0.001

The analysis was unadjusted and adjusted for age and sex. Both models were adjusted for random variation between and within individuals.